Geyer CE Jr, Sikov WM, Huober J, Rugo HS, et al. Long-term efficacy and safety of addition of carboplatin with or without veliparib to standard neoadjuvant chemotherapy in triple-negative breast cancer: 4-year follow-up data from BrighTNess, a randomized phase 3 trial. Ann Oncol 2022 Jan 27. pii: S0923-7534(22)00018.
PMID: 35093516